enVVeno Medical Corporation Completes Rebrand

enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed

enVVeno Medical Corporation (NASDAQ:NVNO) (“enVVeno” or the “Company”), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed its rebranding and that its shares are now trading under the ticker symbol “NVNO” on The Nasdaq Capital Market. The Company was formerly called Hancock Jaffe Laboratories, Inc.

Total
0
Shares
Related Posts